Nominations for the Broermann Medical Innovation Award 2026 Now Open

With a million euros, it is one of the world’s most highly endowed awards for medical research
The Broermann Medical Innovation Award recognizes scientific breakthroughs with high innovation potential for clinical application. The focus is on research results that have a long-lasting impact on the lives and health of millions of people worldwide. The announcement of the award recipient and the second official Broermann Medical Innovation Award ceremony will take place in autumn 2026.
Debut of the Broermann Medical Innovation Award This Year
The award will be presented for the first time this year. The jury will announce the inaugural recipient of the Broermann Medical Innovation Award on September 18, 2025. The official award ceremony, hosted by the Minister-President of Hesse, Boris Rhein, will take place on November 14, 2025, at the Hessian State Chancellery in Wiesbaden.
About the Broermann Medical Innovation Award
The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard groe Broermann, founder of the Asklepios Kliniken Group. The award is endowed by Broermann gemeinntzige GmbH and organized through the University Hospital Gieen and Marburg (UKGM). The award is intended to recognize groundbreaking medical discoveries and highlight those whose research is making real progress in the prevention or treatment of disease. The aim is to reflect the award founder's firm conviction that, although scientific excellence in medicine is always an international team effort, the impact of networks is limited without the genius of individual researchers. The Broermann Medical Innovation Award is intended to recognize and support these key figures and drivers of medical innovation worldwide.
Further information about the award, nomination criteria, and selection process can be found at www.broermann-award.org.
Media Contact
Miriam Malko
+49 641 98542310
[email protected]
Asklepios Kliniken Konzernbereich Unternehmenskommunikation & Marketing
+49 40 1818826636
[email protected]
24-hour press office hotline
+49 40 1818828888
[email protected]
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]
